Spontaneous clearance of hepatitis C genotype 4 after liver retransplantation

H Elsiesy1, F Abaalkhail1, M Al Sebayel1

  • 1Department of Liver and Small Bowel Transplantation and Hepatic-Biliary-Pancreatic Surgery, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.

Insights

Spontaneous clearance of Hepatitis C virus (HCV) after liver retransplantation is exceptionally rare. This case report details the first documented instance of spontaneous HCV genotype 4 clearance post-second liver transplant.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Hepatitis C virus (HCV)-related cirrhosis is a leading cause for liver transplantation globally.
  • Graft reinfection post-transplant is common, leading to significant patient morbidity and mortality.
  • Spontaneous clearance of HCV after liver transplantation, especially retransplantation, is exceedingly rare.

Observation:

  • A 32-year-old female with HCV cirrhosis underwent a second liver transplant in March 2013.
  • She experienced HCV recurrence (genotype 4) post-transplant, with high viral load and intolerance to interferon therapy.
  • HCV RNA levels spontaneously became undetectable shortly after the second transplant, confirmed in May 2013.

Findings:

  • This case represents the first documented spontaneous clearance of Hepatitis C virus genotype 4 following liver retransplantation.
  • The spontaneous viral clearance occurred despite previous recurrence and intolerance to antiviral treatment.
  • The event suggests potential alterations in host immune responses post-retransplantation may contribute to viral clearance.

Implications:

  • This rare event offers insights into the complex host-immune-viral dynamics after liver retransplantation.
  • Further research into immune system modulation post-transplant may reveal novel strategies for managing HCV recurrence.
  • Understanding spontaneous clearance mechanisms could inform future therapeutic approaches for post-transplant Hepatitis C.
Abstract